Here are five facts:
1. Analysts have a 12-month price target of $25.67 on K2M shares.
2. On March 7, Director Carlos Ferrrer bought 38,942 K2M shares in a transaction worth nearly $500,015.
3. Last week, K2M shares opened at $14.07.
4. The company has a market cap of $580.08 million.
5. The 50-day moving average is $12.90 and 200-day moving average is $17.71.
More articles on devices:
Simplifying the joint replacement implant process — OpLogix’s computerized strategy
Spine implant to know: CentraLIF from Globus Medical
Device manufactures turning attention to outpatient setting: 3 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
